graphene-based antibiotic
-
Dr Dube and Greg Fenton on ZEN’s potential graphene-based antibiotic, antiviral and antifungal compound
In a recent InvestorIntel interview, Peter Clausi speaks with Dr. Francis Dube, Executive Chairman, and Greg Fenton, CEO…
-
The marvels of graphene technology kick off 2021 with ZEN focused on our health
While we were getting ready for Christmas, on December 22, 2020, ZEN Graphene Solutions Ltd. (TSXV: ZEN) made…
